A comparative effect of Lekhaniya Mahakashaya Ghan Vati and Mustadi Ghan Vati in the management of Dyslipidemia
Completed
- Conditions
- Mixed hyperlipidemia,
- Registration Number
- CTRI/2017/01/007642
- Lead Sponsor
- Govt Akhandanand Ayurved College and Hospital Bhadra Ahmedabad
- Brief Summary
This study is a randomised, Participant blinded, parallel group, active controlled trial to compare the efficacy of Lekhaniya mahakashaya ghan vati in dose of 6 tablets twice of day with vehicle lukewarm water for 6 weeks in 15 patients of Dyslipidemia and Mustadi ghan vati in dose of 6 tablets twice of day with vehicle lukewarm water for 6 weeks in 15 patients of Dyslipidemia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- 1.If any one or many parameters among lipid profile of an individual found to be in limit stated below,then the subject will be included in the study for objective criteria: Serum cholesterol.
- 200mg/dl or more Serum triglycerides -150mg/dl or more Serum LDL.
- 100mg/dl or more Serum VLDL-10-30mg/dl or more Serum HDL.
- <40mg/dl. 2.Patient’s ongoing anti-hyperlipidemic drugs will be stopped and wash out period will be specified. 3.The main signs and symptoms in the present study will be taken for subjective criteria are as follows- weakness, Fatigue, Paraesthesia, Weight gain, Angachalatva, Alasya, Kshudrashwas, Nidradhikya, Swedadhikya, Daurgandhya , Snigdhata, Atipipasa, Atikshudha, Angagaurava.
Exclusion Criteria
- •Patient having age <18 or >60 yrs.
- •Patient having serious cardiac problems- M.I., Cardiac Failure.
- •Endocrinal disorders will not be taken for study like diabetes mellitus, hypothyroid.
- •Patient having history of obesity and Hyperlipidemia due to drugs e.g. corticosteroids, Antidepressent drugs will not be taken for study.
- •If Lipid profile parameters will come in “very high range, patient will be excluded which is given below- Serum cholesterol- >300mg/dl.
- Serum triglycerides- >500mg/dl.
- Serum LDL ->190mg/dl.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method After completion of the course of the treatment the result will be assessed on the basis of - lipid profile of patients before and after treatment and difference in the score of sign and symptoms of Medoroga and dyslipidemia. 6 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Govt Akhandanand Ayurved College and Hospital & Maniben Ayurved Hospital
🇮🇳Ahmadabad, GUJARAT, India
Govt Akhandanand Ayurved College and Hospital & Maniben Ayurved Hospital🇮🇳Ahmadabad, GUJARAT, IndiaDr Rajneesh PathakPrincipal investigator08866244063drrajneeshpathak5sept@gmail.com